[RESEARCH BLOG] · 2026-09-25
Marex Group plc (MRX) – Sell‑Signal Triggered in a Bear‑Regime Amid Slowing Momentum
By Pierre Brunelle · Founder & Research Lead
Marex Group plc closed at $71.31, down 1.90 % as of 2026‑09‑25 (Friday, US session). The LOPJLB proprietary scanner now flags a SELL directional signal with a ‑5 score, situating the stock in a BEAR market regime.
Marex’s recent headlines have been a mixture of optimism and caution. Marex Stock Doubles on Record Profits, But Can the Rally Continue? reported on 2026‑09‑16 that the stock had “doubled on record profits,” highlighting a surge in earnings that propelled the share price to new highs. The article noted that the company posted a record‑breaking net profit for the fiscal year, driven by higher clearing volumes and expanded market‑making activities across its commodity and financial platforms.
In the same day’s coverage, Marex Group plc Ordinary Shares (NASDAQ:MRX) Receives $82.00 Consensus PT from Analysts disclosed that analysts have converged on a consensus 82.00 for MRX, up from prior expectations. The consensus reflects a modest upside of roughly 15 % from the current market price, but the report also warned that the target assumes continued growth in trading volumes and stable margin compression.
Earlier, Marex Group PLC (MRX) is a Great Momentum Stock: ? ran a piece on 2026‑09‑08 branding Marex as a “great momentum stock” and questioning whether the rally could sustain its pace. The analysis cited the stock’s 13‑month price appreciation of over 30 % and a forward P/E of 11.9x, yet it flagged rising debt levels and a D/E ratio of 150.8% as potential headwinds.
A separate Can Marex Group PLC (MRX) Run Higher on Rising Earnings Estimates? story from 2026‑08‑18 examined whether rising earnings estimates could push MRX higher, pointing to the company’s forward‑looking earnings guidance that projects EPS of $5.00 for FY 2026, a near‑double increase from the prior year. The piece emphasized that the upside is contingent on the firm’s ability to maintain its gross margin of 59.5 % while expanding its operating margin beyond the current 43.8 %.
Finally, Great Lakes Advisors LLC Invests $191,000 in Marex Group plc Ordinary Shares $MRX disclosed a $191,000 equity stake in MRX on 2026‑08‑25, indicating continued institutional interest despite the broader market’s bearish tilt. The filing noted that the investment aligns with the fund’s focus on dividend‑paying, high‑ROE financial services firms.
Fundamentals and Valuation
Marex’s valuation metrics sit at the lower end of the sector spectrum, suggesting a degree of cheapness relative to peers. The trailing twelve‑month (TTM) P/E stands at 18.15×, while the forward P/E compresses to 11.95×, reflecting expectations of accelerating earnings growth. The EV/EBITDA multiple of 2.68× is well below the industry average of roughly 7‑8×, underscoring the company’s relatively low enterprise value given its cash‑flow generation.
A snapshot of key valuation ratios is shown below:
| Metric | Value |
|---|---|
| P/E (TTM) | 18.15 |
| P/E (Forward) | 11.95 |
| EV/EBITDA | 2.68 |
| P/B | 2.88 |
| PEG | 1.00 |
| Dividend Yield | 0.87 % |
Marex’s profitability remains robust. The gross margin of 59.49 % and operating margin of 43.75 % indicate a strong cost structure, while the net margin of 9.67 % reflects the impact of financing costs and tax. The firm’s return on invested capital (ROIC) is 19.11 %, and return on equity (ROE) is an impressive 31.85 %, both well above the sector average of roughly 12‑15 %. Return on assets (ROA) sits at 1.19 %, modest but consistent with a capital‑intensive business model.
The balance sheet shows a debt‑to‑equity (D/E) ratio of 150.8 %, indicating a leveraged capital structure. Nevertheless, the company’s cash‑flow generation has been strong: free cash flow (FCF) rose from a negative $49.1 m in 2020 to $654.4 m in 2025, reflecting the firm’s transition from a cash‑burn phase to a cash‑generating engine.
Revenue has accelerated sharply over the past six years, climbing from $757.5 m in 2020 to $3.63 bn in 2025, a compound annual growth rate (CAGR) of roughly 35 %. EPS has mirrored this trajectory, moving from $0.72 in 2020 to $4.13 in 2025, a more than five‑fold increase. The price‑to‑earnings (P/E) ratio has compressed from 26.27× in 2020 to 8.88× in 2025, reflecting both earnings acceleration and a modest price appreciation relative to earnings.
The company’s dividend policy remains modest, with a yield of 0.87 % and a payout ratio that aligns with its “Dividend Compounder” archetype. Analysts collectively assign a Buy recommendation and a consensus target price of $81.83, implying a 15 % upside from the current level. However, the value score of 47.00 (on a 0‑100 scale) signals that the stock is not a deep value play, while the growth score of 59.00 and GARP score of 76.20 suggest a blend of growth and quality attributes.
Historical Performance Highlights
| Fiscal Year | Revenue (US$ m) | EPS (US$) | FCF (US$ m) | Net Margin % | ROE % |
|---|---|---|---|---|---|
| 2020 | 757.5 | 0.72 | -49.1 | 5.79 | 9.87 |
| 2021 | 851.7 | 0.80 | 463.5 | 6.63 | 11.83 |
| 2022 | 1,175.3 | 1.29 | 216.2 | 7.79 | 13.52 |
| 2023 | 2,352.3 | 1.94 | 722.9 | 5.44 | 16.50 |
| 2024 | 2,894.8 | 2.72 | 1,143.6 | 7.53 | 22.32 |
| 2025 | 3,629.8 | 4.13 | 654.4 | 8.49 | 24.39 |
The table illustrates a four‑fold revenue expansion from 2020 to 2025, accompanied by a steady rise in profitability and ROE that now exceeds 24 %. The net margin dipped in 2023 amid higher operating costs but rebounded in 2024 and 2025, reflecting the firm’s ability to manage cost pressures while scaling its platform.
ETF Ownership
Marex is held across a modest set of exchange‑traded funds, with the top twelve ETFs accounting for roughly 15 % of the float. The largest holders are TAOZ (2.60 %), TFGZ (2.52 %), and AMID (2.24 %), each of which is a multi‑asset or thematic fund with exposure to financial services and commodities. Concentrated ETF ownership can amplify price moves when fund managers rebalance, especially in a bear regime where outflows may trigger additional selling pressure.
| ETF Ticker | Weight % |
|---|---|
| TAOZ | 2.60 |
| TFGZ | 2.52 |
| AMID | 2.24 |
| TSME | 1.34 |
| NBCC | 1.19 |
| TMSL | 0.84 |
| PSC | 0.81 |
| SGRW | 0.81 |
| EBIT | 0.77 |
| FFSM | 0.71 |
| FSMO | 0.71 |
| FPXE | 0.59 |
The presence of these ETFs underscores a moderate institutional footprint, which can be a double‑edged sword: it provides liquidity but also makes the stock susceptible to systematic ETF flows.
LOPJLB Signal Read
The LOPJLB engine currently issues a SELL directional signal for MRX, with a score of –5 in a BEAR market regime. The composite PERF rating sits at 71.30, while the FUND quality score is 76.10, reflecting a solid underlying business but a deteriorating short‑term price outlook. The stock’s Value score (47.00) is below the midpoint, whereas the Growth (59.00) and GARP (76.20) scores are higher, indicating that the market is pricing in growth expectations more than pure valuation discounts.
The archetype assigned by LOPJLB is “Dividend Compounder,” consistent with the modest dividend yield and the firm’s historical ability to reinvest earnings while returning cash to shareholders. Investors can explore the full overlay of technical signals, including the EMA crossover, momentum, and volatility metrics, on the interactive chart above on this page. For a deeper dive into the methodology behind these scores, see the LOPJLB methodology page.
Explore further:
- Detailed stock page: https://www.lopjlb.com/stock/MRX
- Earnings transcript (if applicable): https://www.lopjlb.com/stock/MRX/earnings.md
- Full‑screen screener for similar opportunities: https://www.lopjlb.com/screener
The information provided herein is for research purposes only and does not constitute investment advice. All data is sourced from publicly available filings and third‑party providers. Readers should conduct their own due diligence before making any investment decisions.
This post is independent quantitative research, not investment advice. LOPJLB signals are model outputs derived from price, volume, and fundamentals. Past backtests do not guarantee future results. Position sizing, execution, and risk management remain the reader's responsibility.